Cryo-Cell International Total Current Liabilities

Cryo-Cell International (CCEL) currently reports a total current liabilities of $15M as of August 2026. That compares with $18M in the prior-year period — down 16.9% year over year. Use the charts on this page to explore Cryo-Cell International's total current liabilities history and peer comparisons.

Cryo-Cell International's total current liabilities decreased from $18M to $15M — a 16.9% year-over-year decrease (period ending August 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cryo-Cell International reported $15M in total current liabilities as of August 2026. That compares with $18M in the prior-year period — down 16.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cryo-Cell International, and consider following CCEL for alerts when major investors trade the stock.

Cryo-Cell International is classified in the Healthcare sector. On total current liabilities, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CCEL with unrelated industries.